Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology

Free Medical Books

  Biliary Tract Diseases

  Free Subscription


Articles published in Hepatology

Retrieve available abstracts of 151 articles:
HTML format
Text format



Single Articles


    January 2012
  1. HARADA K , Shimoda S, Kimura Y, Sato Y, et al
    Significance of IgG4-positive cells in extrahepatic cholangiocarcinoma: Molecular mechanism of IgG4 reaction in cancer tissue.
    Hepatology. 2012 Jan 30. doi: 10.1002/hep.25627.
    PubMed     Text format     Related articles    Abstract available



  2. JANG JH , Rickenbacher A, Humar B, Weber A, et al
    Serotonin protects mouse liver from cholestatic injury by decreasing bile salt pool after bile duct ligation.
    Hepatology. 2012 Jan 30. doi: 10.1002/hep.25626.
    PubMed     Text format     Related articles    Abstract available



  3. TANAKA N , Matsubara T, Krausz KW, Patterson AD, et al
    Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis.
    Hepatology. 2012 Jan 30. doi: 10.1002/hep.25630.
    PubMed     Text format     Related articles    Abstract available



  4. MURAD SD , Ray Kim W, Therneau T, Gores GJ, et al
    Predictors of pre-transplant dropout and post-transplant recurrence in patients with perihilar cholangiocarcinoma.
    Hepatology. 2012 Jan 30. doi: 10.1002/hep.25629.
    PubMed     Text format     Related articles    Abstract available



  5. FUJIWARA K , Yokosuka O
    Frequent detection of IgM anti-herpes simplex viral antibody in patients with primary biliary cirrhosis.
    Hepatology. 2012 Jan 23. doi: 10.1002/hep.25597.
    PubMed     Text format     Related articles   



  6. KOMUTA M , Govaere O, Vandecaveye V, Akiba J, et al
    Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes.
    Hepatology. 2012 Jan 23. doi: 10.1002/hep.25595.
    PubMed     Text format     Related articles    Abstract available



  7. PORTINCASA P , Wang DQ
    Intestinal absorption, hepatic synthesis, and biliary secretion of cholesterol: Where are we for cholesterol gallstone formation?
    Hepatology. 2012 Jan 23. doi: 10.1002/hep.25604.
    PubMed     Text format     Related articles   



  8. CORPECHOT C , Carrat F, Poujol-Robert A, Gaouar F, et al
    Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis.
    Hepatology. 2012 Jan 23. doi: 10.1002/hep.25599.
    PubMed     Text format     Related articles    Abstract available



  9. GORES G , Lindor KD, Razumilava N
    RE: Gall bladder polyps in primary sclerosing cholangitis- adhere to the guidelines HEP-11-2164.
    Hepatology. 2012 Jan 19. doi: 10.1002/hep.25585.
    PubMed     Text format     Related articles   



  10. NAKANUMA Y , Sato Y
    Cystic and papillary neoplasm involving peribiliary glands: A biliary counterpart of branch-type IPMN?
    Hepatology. 2012 Jan 19. doi: 10.1002/hep.25590.
    PubMed     Text format     Related articles   



  11. SCHRAMM C , Lohse AW
    Gall bladder polyps in primary sclerosing cholangitis - indication for early intervention.
    Hepatology. 2012 Jan 19. doi: 10.1002/hep.25589.
    PubMed     Text format     Related articles   



  12. CARDINALE V , Wang Y, Carpino G, Reid LM, et al
    Mucin-producing cholangiocarcinoma might derive from biliary tree stem/progenitor cells located in peribiliary glands.
    Hepatology. 2012 Jan 19. doi: 10.1002/hep.25587.
    PubMed     Text format     Related articles   



  13. SEOK JY , Na DC, Woo HG, Roncalli M, et al
    A fibrous stromal component in hepatocellular carcinoma reveals a cholangiocarcinoma-like gene expression trait and EMT.
    Hepatology. 2012 Jan 11. doi: 10.1002/hep.25570.
    PubMed     Text format     Related articles    Abstract available



    December 2011
  14. CHEN Q , Li W, Wan Y, Xia X, et al
    The AIB1 oncogene enhances human cholangiocarcinoma growth and chemoresistance by simultaneous activation of Akt and Nrf2 pathways.
    Hepatology. 2011 Dec 27. doi: 10.1002/hep.25549.
    PubMed     Text format     Related articles    Abstract available



  15. KRAWCZYK M , Lutjohann D, Schirin-Sokhan R, Villarroel L, et al
    Phytosterol and cholesterol precursor levels indicate increased cholesterol excretion and biosynthesis in gallstone patients.
    Hepatology. 2011 Dec 27. doi: 10.1002/hep.25563.
    PubMed     Text format     Related articles    Abstract available



  16. LAM P , Xu S, Soroka CJ, Boyer JL, et al
    A c-terminal tyrosine-based motif in the bile salt export pump directs clathrin-dependent endocytosis.
    Hepatology. 2011 Dec 12. doi: 10.1002/hep.25523.
    PubMed     Text format     Related articles    Abstract available



    November 2011
  17. KIM YC , Park MS
    Distal common bile duct (CBD) metastasis from hepatocelluar carcinoma (HCC).
    Hepatology. 2011 Nov 26. doi: 10.1002/hep.25502.
    PubMed     Text format     Related articles   



  18. BRINDLEY SM , Lanham AM, Karrer FM, Tucker RM, et al
    Cytomegalovirus-specific T cell reactivity in biliary atresia at the time of diagnosis is associated with deficits in regulatory T cells.
    Hepatology. 2011 Nov 22. doi: 10.1002/hep.24807.
    PubMed     Text format     Related articles    Abstract available



  19. CHAI J , He Y, Cai SY, Jiang Z, et al
    Elevated hepatic MRP3/ABCC3 expression in human obstructive cholestasis is mediated through TNFalpha and JNK/SAPK signaling pathway.
    Hepatology. 2011 Nov 22. doi: 10.1002/hep.24801.
    PubMed     Text format     Related articles    Abstract available



  20. MOLHO-PESSACH V , Rios JJ, Xing C, Setchell KD, et al
    Homozygosity mapping identifies a bile acid biosynthetic defect in an adult with cirrhosis of unknown etiology.
    Hepatology. 2011 Nov 16. doi: 10.1002/hep.24781.
    PubMed     Text format     Related articles    Abstract available



    October 2011
  21. FINGAS CD , Bronk SF, Werneburg NW, Mott JL, et al
    Myofibroblast-derived PDGF-BB promotes hedgehog survival signaling in cholangiocarcinoma cells.
    Hepatology. 2011 Oct 28. doi: 10.1002/hep.24588.
    PubMed     Text format     Related articles    Abstract available



  22. TAKAHASHI T , Miura T, Nakamura J, Yamada S, et al
    Plasma cells and the chronic nonsuppurative destructive cholangitis of primary biliary cirrhosis.
    Hepatology. 2011 Oct 26. doi: 10.1002/hep.24757.
    PubMed     Text format     Related articles    Abstract available



  23. GROSSE B , Cassio D, Yousef N, Bernardo C, et al
    Claudin-1 involved in neonatal ichthyosis - sclerosing cholangitis syndrome, regulates hepatic paracellular permeability.
    Hepatology. 2011 Oct 26. doi: 10.1002/hep.24761.
    PubMed     Text format     Related articles    Abstract available



  24. TSUDA M , Moritoki Y, Lian ZX, Zhang W, et al
    Biochemical and immunologic effects of rituximab in primary biliary cirrhosis patients with an incomplete response to ursodeoxycholic acid.
    Hepatology. 2011 Oct 17. doi: 10.1002/hep.24748.
    PubMed     Text format     Related articles    Abstract available



  25. SPIRLI C , Locatelli L, Fiorotto R, Morell CM, et al
    Altered store operated calcium entry increases cAMP production and ERK1/2 phosphorylation in Polycystin-2 defective cholangiocytes.
    Hepatology. 2011 Oct 10. doi: 10.1002/hep.24723.
    PubMed     Text format     Related articles    Abstract available



  26. BAGHDASARYAN A , Claudel T, Gumhold J, Silbert D, et al
    Dual farnesoid X receptor/TGR5 agonist INT-767 reduces liver injury in the Mdr2(-/-) (Abcb4(-/-) ) mouse cholangiopathy model by promoting biliary HCO 3- output.
    Hepatology. 2011;54:1303-12.
    PubMed     Text format     Related articles    Abstract available



    September 2011
  27. UMEMURA T , Joshita S, Ichijo T, Yoshizawa K, et al
    HLA class II molecules confer both susceptibility and progression in Japanese patients with primary biliary cirrhosis.
    Hepatology. 2011 Sep 27. doi: 10.1002/hep.24705.
    PubMed     Text format     Related articles    Abstract available



  28. ZWEERS SJ , Booij KA, Komuta M, Roskams T, et al
    The human gallbladder secretes fibroblast growth factor 19 (FGF19) into bile: Towards defining the role of FGF19 in the enterobiliary tract.
    Hepatology. 2011 Sep 27. doi: 10.1002/hep.24702.
    PubMed     Text format     Related articles    Abstract available



  29. RAZUMILAVA N , Bronk SF, Smoots RL, Fingas CD, et al
    miR-25 targets TRAIL death Receptor-4 and promotes apoptosis resistance in cholangiocarcinoma.
    Hepatology. 2011 Sep 27. doi: 10.1002/hep.24698.
    PubMed     Text format     Related articles    Abstract available



  30. STUDER E , Zhou X, Zhao R, Wang Y, et al
    Conjugated bile acids activate the sphingosine-1-phosphate receptor 2 in primary rodent hepatocytes.
    Hepatology. 2011 Sep 19. doi: 10.1002/hep.24681.
    PubMed     Text format     Related articles    Abstract available



  31. HOHENESTER S , de Buy Wenniger LM, Paulusma CC, van Vliet SJ, et al
    A biliary HCO(3) (-) umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes.
    Hepatology. 2011 Sep 19. doi: 10.1002/hep.24691.
    PubMed     Text format     Related articles    Abstract available



  32. HUANG HP , Chang MH, Chen YT, Hsu HY, et al
    Persistent elevation of hepatocyte growth factor activator inhibitors in cholangiopathies affects liver fibrosis and differentiation.
    Hepatology. 2011 Sep 2. doi: 10.1002/hep.24657.
    PubMed     Text format     Related articles    Abstract available



    August 2011
  33. VANDERPOOL C , Sparks EE, Huppert KA, Gannon M, et al
    Genetic interactions between hepatocyte nuclear factor-6 and notch signaling regulate mouse intrahepatic bile duct development in vivo.
    Hepatology. 2011 Aug 24. doi: 10.1002/hep.24631.
    PubMed     Text format     Related articles    Abstract available



  34. LLEO A , Liao J, Invernizzi P, Zhao M, et al
    IgM levels inversely correlate with cd40l promoter methylation in patients with primary biliary cirrhosis Hepatology-Ana lleo library 4-26.
    Hepatology. 2011 Aug 24. doi: 10.1002/hep.24630.
    PubMed     Text format     Related articles    Abstract available



  35. NODA T , Shimoda M, Ortiz V, Sirica AE, et al
    Immunization with ASPH-loaded dendritic cells produces anti-tumor effects in a rat model of intrahepatic cholangiocarcinoma.
    Hepatology. 2011 Aug 24. doi: 10.1002/hep.24629.
    PubMed     Text format     Related articles    Abstract available



  36. MCNALLY RJ , James PW, Ducker S, James OF, et al
    Seasonal variation in the diagnosis of primary biliary cirrhosis: Further evidence for an environmental component to etiology.
    Hepatology. 2011 Aug 8. doi: 10.1002/hep.24597.
    PubMed     Text format     Related articles    Abstract available



  37. OLARU AV , Ghiaur G, Yamanaka S, Luvsanjav D, et al
    A microRNA downregulated in human cholangiocarcinoma controls cell cycle through multiple targets involved in the G1/S checkpoint.
    Hepatology. 2011 Aug 1. doi: 10.1002/hep.24591.
    PubMed     Text format     Related articles    Abstract available



  38. CARDINALE V , Wang Y, Carpino G, Cui CB, et al
    Multipotent stem/progenitor cells in human biliary tree give rise to hepatocytes, cholangiocytes and pancreatic islets.
    Hepatology. 2011 Aug 1. doi: 10.1002/hep.24590.
    PubMed     Text format     Related articles    Abstract available



  39. MIRAGOLI M , Kadir SH, Sheppard MN, Salvarani N, et al
    A protective antiarrhythmic role of ursodeoxycholic acid in an in vitro rat model of the cholestatic fetal heart.
    Hepatology. 2011 Aug 1. doi: 10.1002/hep.24492.
    PubMed     Text format     Related articles    Abstract available



  40. WELZEL TM , Graubard BI, Zeuzem S, El-Serag HB, et al
    Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database.
    Hepatology. 2011;54:463-71.
    PubMed     Text format     Related articles    Abstract available



    July 2011
  41. VANWIJNGAERDEN YM , Wauters J, Langouche L, Vander Perre S, et al
    Critical illness evokes elevated circulating bile acids related to altered hepatic transporter and nuclear receptor expression.
    Hepatology. 2011 Jul 28. doi: 10.1002/hep.24582.
    PubMed     Text format     Related articles    Abstract available



  42. MENG F , Han Y, Staloch D, Francis T, et al
    The H4HR agonist, clobenpropit, suppresses human cholangiocarcinoma progression by disruption of EMT and tumor metastasis.
    Hepatology. 2011 Jul 25. doi: 10.1002/hep.24573.
    PubMed     Text format     Related articles    Abstract available



  43. RAZUMILAVA N , Gores GJ, Lindor KD
    Cancer surveillance in patients with primary sclerosing cholangitis.
    Hepatology. 2011 Jul 25. doi: 10.1002/hep.24570.
    PubMed     Text format     Related articles    Abstract available



  44. MANOHAR R , Komori J, Guzik L, Stolz DB, et al
    Identification and expansion of a unique stem cell population from adult mouse gallbladder.
    Hepatology. 2011 Jul 25. doi: 10.1002/hep.24568.
    PubMed     Text format     Related articles    Abstract available



  45. KRUGLOV EA , Gautam S, Guerra MT, Nathanson MH, et al
    Type 2 inositol 1,4,5-trisphosphate receptor modulates bile salt export pump activity in rat hepatocytes.
    Hepatology. 2011 Jul 11. doi: 10.1002/hep.24548.
    PubMed     Text format     Related articles    Abstract available



  46. GIRARD M , Jannot AS, Besnard M, Leutenegger AL, et al
    Polynesian ecology determines seasonality of biliary atresia.
    Hepatology. 2011 Jul 11. doi: 10.1002/hep.24534.
    PubMed     Text format     Related articles   



  47. TSUDA M , Ambrosini YM, Zhang W, Yang GX, et al
    Fine phenotypic and functional characterization of effector CD8(+) T cells in patients with primary biliary cirrhosis.
    Hepatology. 2011 Jul 6. doi: 10.1002/hep.24526.
    PubMed     Text format     Related articles    Abstract available



  48. WANG YD , Chen WD, Yu D, Forman BM, et al
    The G-protein coupled bile acid receptor Gpbar1 (TGR5) negatively regulates hepatic inflammatory response through antagonizing Nuclear Factor kappaB.
    Hepatology. 2011 Jul 6. doi: 10.1002/hep.24525.
    PubMed     Text format     Related articles    Abstract available



  49. NAIR SS , Bommana A, Pakala SB, Ohshiro K, et al
    Inflammatory response to liver fluke Opisthorchis viverrini depends on host master coregulator, MTA1, a marker for parasite induced cholangiocarcinoma.
    Hepatology. 2011 Jul 2. doi: 10.1002/hep.24518.
    PubMed     Text format     Related articles    Abstract available



    June 2011
  50. CHEN F , Shyu AB, Shneider BL
    Hu antigen R and tristetraprolin - counter-regulators of rat apical sodium dependent bile acid transporter via effects on mRNA stability.
    Hepatology. 2011 Jun 17. doi: 10.1002/hep.24496.
    PubMed     Text format     Related articles    Abstract available



  51. OSEINI AM , Chaiteerakij R, Shire AM, Ghazale A, et al
    The utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-Associated cholangitis from cholangiocarcinoma.
    Hepatology. 2011 Jun 14. doi: 10.1002/hep.24487.
    PubMed     Text format     Related articles    Abstract available



  52. YU HC , Hsu YH, Hu CT
    A woman with improving cholestasis but hepatitis aggravating.
    Hepatology. 2011;53:2137-8.
    PubMed     Text format     Related articles   



  53. CHAPMAN R
    Genome-wide association studies in primary sclerosing cholangitis: Still more questions than answers?
    Hepatology. 2011;53:2133-5.
    PubMed     Text format     Related articles   



  54. DONALDSON PT
    Electrostatic modifications of the human leukocyte antigen DR P9 peptide-binding pocket in primary sclerosing cholangitis: back to the future with human leukocyte antigen DRbeta.
    Hepatology. 2011;53:1798-800.
    PubMed     Text format     Related articles   



    May 2011
  55. FABRIS L , Cadamuro M, Moserle L, Dziura J, et al
    Nuclear expression of S100A4 calcium binding protein increases cholangiocarcinoma invasiveness and metastasization.
    Hepatology. 2011 May 26. doi: 10.1002/hep.24466.
    PubMed     Text format     Related articles    Abstract available



  56. CUI W , Matsuno K, Iwata K, Ibi M, et al
    NADPH oxidase NOX1 promotes proliferation of stellate cells and aggravates liver fibrosis induced by bile duct ligation.
    Hepatology. 2011 May 26. doi: 10.1002/hep.24465.
    PubMed     Text format     Related articles    Abstract available



  57. ZHANG J , Handy DE, Wang Y, Bouchard G, et al
    Hyperhomocysteinemia from trimethylation of hepatic phosphatidylethanolamine during cholesterol cholelithogenesis in inbred mice.
    Hepatology. 2011 May 12. doi: 10.1002/hep.24428.
    PubMed     Text format     Related articles    Abstract available



  58. INVERNIZZI P
    HLA in primary biliary cirrhosis: An old story now reviving.
    Hepatology. 2011 May 11. doi: 10.1002/hep.24414.
    PubMed     Text format     Related articles    Abstract available



  59. HOFMANN AF
    Bile acid sequestrants improve glycemic control in type 2 diabetes: A proposed mechanism implicating glucagon-like peptide 1 release.
    Hepatology. 2011;53:1784.
    PubMed     Text format     Related articles   



  60. CHU AS , Diaz R, Hui JJ, Yanger K, et al
    Lineage tracing demonstrates no evidence of cholangiocyte epithelial-to-mesenchymal transition in murine models of hepatic fibrosis.
    Hepatology. 2011;53:1685-95.
    PubMed     Text format     Related articles   



    April 2011
  61. RONG G , Zhong R, Lleo A, Leung PS, et al
    Epithelial cell specificity and apotope recognition by serum autoantibodies in primary biliary cirrhosis.
    Hepatology. 2011 Apr 12. doi: 10.1002/hep.24355.
    PubMed     Text format     Related articles    Abstract available



  62. TYSON GL , El-Serag HB
    Risk factors of cholangiocarcinoma.
    Hepatology. 2011 Apr 12. doi: 10.1002/hep.24351.
    PubMed     Text format     Related articles    Abstract available



  63. WILDHABER BE
    Screening for biliary atresia: Swiss stool color card.
    Hepatology. 2011 Apr 12. doi: 10.1002/hep.24346.
    PubMed     Text format     Related articles   



  64. PADDA MS , Sanchez M, Akhtar AJ, Boyer JL, et al
    Drug-induced cholestasis.
    Hepatology. 2011;53:1377-87.
    PubMed     Text format     Related articles    Abstract available



  65. DEOLIVEIRA ML , Schulick RD, Nimura Y, Rosen C, et al
    New staging system and a registry for perihilar cholangiocarcinoma.
    Hepatology. 2011;53:1363-71.
    PubMed     Text format     Related articles    Abstract available



  66. KIREVA T , Erhardt A, Tiegs G, Tilg H, et al
    Transcription factor Fra-1 induces cholangitis and liver fibrosis.
    Hepatology. 2011;53:1287-97.
    PubMed     Text format     Related articles    Abstract available



  67. MATSUBARA T , Tanaka N, Patterson AD, Cho JY, et al
    Lithocholic acid disrupts phospholipid and sphingolipid homeostasis leading to cholestasis in mice.
    Hepatology. 2011;53:1282-93.
    PubMed     Text format     Related articles    Abstract available



  68. OMENETTI A , Bass LM, Anders RA, Clemente MG, et al
    Hedgehog activity, epithelial-mesenchymal transitions, and biliary dysmorphogenesis in biliary atresia.
    Hepatology. 2011;53:1246-58.
    PubMed     Text format     Related articles    Abstract available



  69. FWU CW , Chien YC, You SL, Nelson KE, et al
    Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: A cohort study of parous women in Taiwan.
    Hepatology. 2011;53:1217-25.
    PubMed     Text format     Related articles    Abstract available



    March 2011
  70. JANSE M , Lamberts LE, Franke L, Raychaudhuri S, et al
    Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL and CARD9.
    Hepatology. 2011 Mar 21. doi: 10.1002/hep.24307.
    PubMed     Text format     Related articles    Abstract available



  71. HOV JR , Kosmoliaptsis V, Traherne JA, Olsson M, et al
    Electrostatic modifications of the HLA-DR P9 peptide-binding pocket and susceptibility to primary sclerosing cholangitis.
    Hepatology. 2011 Mar 16. doi: 10.1002/hep.24299.
    PubMed     Text format     Related articles    Abstract available



  72. RAYNAUD P , Tate J, Callens C, Cordi S, et al
    A classification of ductal plate malformations based on distinct pathogenic mechanisms of biliary dysmorphogenesis.
    Hepatology. 2011 Mar 9. doi: 10.1002/hep.24292.
    PubMed     Text format     Related articles    Abstract available



  73. OUT C , Hageman J, Bloks VW, Gerrits H, et al
    LRH-1 is critical for adequate upregulation of Cyp7a1 gene transcription and bile salt synthesis during bile salt sequestration.
    Hepatology. 2011 Mar 9. doi: 10.1002/hep.24286.
    PubMed     Text format     Related articles    Abstract available



  74. GAO B , Bertola A
    Natural killer cells take two tolls to destruct bile ducts.
    Hepatology. 2011 Mar 7. doi: 10.1002/hep.24275.
    PubMed     Text format     Related articles   



  75. BOSOI CR , Parent-Robitaille C, Anderson K, Tremblay M, et al
    AST-120 (spherical carbon adsorbent) lowers ammonia levels and attenuates brain edema in bile-duct ligated rats.
    Hepatology. 2011 Mar 7. doi: 10.1002/hep.24273.
    PubMed     Text format     Related articles    Abstract available



  76. WU SJ , Yang YH, Tsuneyama K, Leung PS, et al
    Innate immunity and primary biliary cirrhosis: Activated invariant natural killer T cells exacerbate murine autoimmune cholangitis and fibrosis.
    Hepatology. 2011;53:915-25.
    PubMed     Text format     Related articles    Abstract available



  77. LANKISCH TO , Metzger J, Negm AA, Vobetakuhl K, et al
    Bile proteomic profiles differentiate cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasis.
    Hepatology. 2011;53:875-884.
    PubMed     Text format     Related articles    Abstract available



  78. WAGNER M , Zollner G, Trauner M
    Nuclear receptors in liver disease.
    Hepatology. 2011;53:1023-34.
    PubMed     Text format     Related articles    Abstract available



    February 2011
  79. MOLODECKY NA , Kareemi H, Parab R, Barkema HW, et al
    The incidence of primary sclerosing cholangitis: A systematic review and meta-analysis.
    Hepatology. 2011 Feb 23. doi: 10.1002/hep.24247.
    PubMed     Text format     Related articles    Abstract available



  80. SHIMODA S , Harada K, Niiro H, Shirabe K, et al
    Interaction between Toll-like receptors and natural killer cells in the destruction of bile ducts in primary biliary cirrhosis.
    Hepatology. 2011 Feb 14. doi: 10.1002/hep.24194.
    PubMed     Text format     Related articles    Abstract available



  81. ZHU AX , Hezel AF
    Development of molecularly targeted therapies in biliary tract cancers: Reassessing the challenges and opportunities.
    Hepatology. 2011;53:695-704.
    PubMed     Text format     Related articles    Abstract available



  82. STENDER S , Frikke-Schmidt R, Nordestgaard BG, Tybjaerg-Hansen A, et al
    Sterol transporter adenosine triphosphate-binding cassette transporter G8, gallstones, and biliary cancer in 62,000 individuals from the general population.
    Hepatology. 2011;53:640-8.
    PubMed     Text format     Related articles    Abstract available



  83. ALPINI G , Franchitto A, Demorrow S, Onori P, et al
    Activation of alpha(1) -adrenergic receptors stimulate the growth of small mouse cholangiocytes Via calcium-dependent activation of nuclear factor of activated T cells 2 and specificity protein 1.
    Hepatology. 2011;53:628-39.
    PubMed     Text format     Related articles    Abstract available



  84. HE H , Mennone A, Boyer JL, Cai SY, et al
    Combination of retinoic acid and ursodeoxycholic acid attenuates liver injury in bile duct-ligated rats and human hepatic cells.
    Hepatology. 2011;53:548-57.
    PubMed     Text format     Related articles    Abstract available



  85. DHIRAPONG A , Lleo A, Yang GX, Tsuneyama K, et al
    B cell depletion therapy exacerbates murine primary biliary cirrhosis.
    Hepatology. 2011;53:527-35.
    PubMed     Text format     Related articles    Abstract available



  86. LEVEEN P , Kotarsky H, Morgelin M, Karikoski R, et al
    The GRACILE mutation introduced into Bcs1l causes postnatal complex III deficiency: A viable mouse model for mitochondrial hepatopathy.
    Hepatology. 2011;53:437-47.
    PubMed     Text format     Related articles    Abstract available



  87. LIASKOU E , Karikoski M, Reynolds GM, Lalor PF, et al
    Regulation of mucosal addressin cell adhesion molecule 1 expression in human and mice by vascular adhesion protein 1 amine oxidase activity.
    Hepatology. 2011;53:661-72.
    PubMed     Text format     Related articles    Abstract available



  88. JONES DE , Newton JL
    The complexity of fatigue.
    Hepatology. 2011;53:717-8.
    PubMed     Text format     Related articles   



    January 2011
  89. LIU Z , Ma Y, Qin H
    Combinative strategy using tamoxifen and other chemotherapeutic drugs for cholangiocarcinoma chemotherapy.
    Hepatology. 2011;53:375-6.
    PubMed     Text format     Related articles   



  90. JONES DE , Mells G
    The genetics of primary biliary cirrhosis: The revolution moves on.
    Hepatology. 2011;53:362-4.
    PubMed     Text format     Related articles   



  91. LIEN TH , Chang MH, Wu JF, Chen HL, et al
    Effects of the infant stool color card screening program on 5-year outcome of biliary atresia in taiwan.
    Hepatology. 2011;53:202-208.
    PubMed     Text format     Related articles    Abstract available



    December 2010
  92. LI T , Matozel M, Boehme S, Kong B, et al
    Overexpression of cholesterol 7alpha-hydroxylase promotes hepatic bile acid synthesis and secretion and maintains cholesterol homeostasis.
    Hepatology. 2010 Dec 14. doi: 10.1002/hep.24107.
    PubMed     Text format     Related articles    Abstract available



  93. LANKISCH TO , Metzger J, Negm AA, Vobetakuhl K, et al
    Bile proteomic profiles differentiate cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasis.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  94. HOFMANN AF
    Bile acid sequestrants improve glycemic control in type 2 diabetes: A proposed mechanism implicating glucagon-like peptide 1 release.
    Hepatology. 2010.
    PubMed     Text format     Related articles   



  95. MATTHEWS RP , Eauclaire SF, Mugnier M, Lorent K, et al
    DNA hypomethylation causes bile duct defects in zebrafish and is a distinguishing feature of infantile biliary atresia.
    Hepatology. 2010 Dec 7. doi: 10.1002/hep.24106.
    PubMed     Text format     Related articles    Abstract available



  96. MACARON C , Hanouneh IA, Zein NN
    Incidence and risk factors of hepatocellular carcinoma in patients with primary biliary cirrhosis.
    Hepatology. 2010;52:2240.
    PubMed     Text format     Related articles   



  97. MACARON C , Hanouneh IA, Zein NN
    Incidence and risk factors of hepatocellular carcinoma in patients with primary biliary cirrhosis.
    Hepatology. 2010;52:2240.
    PubMed     Text format     Related articles   



  98. PARSI MA
    Hemobilia: endoscopic, fluoroscopic, and cholangioscopic diagnosis.
    Hepatology. 2010;52:2237-8.
    PubMed     Text format     Related articles   



    November 2010
  99. DENK GU , Maitz S, Wimmer R, Rust C, et al
    Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid-induced cholestasis in rat liver.
    Hepatology. 2010;52:1758-68.
    PubMed     Text format     Related articles    Abstract available



    October 2010
  100. HE H , Mennone A, Boyer JL, Cai SY, et al
    combination of retinoic acid and ursodeoxycholic acid attenuates liver injury in bile duct-ligated rats and human hepatic cells.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  101. STENDER S , Frikke-Schmidt R, Nordestgaard BG
    Sterol transporter adenosine triphosphate-binding cassette transporter G8, gallstones, and biliary cancer in 62,000 individuals from the general population.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  102. ALPINI G , Franchitto A, Demorrow S, Onori P, et al
    Activation of alpha(1)-adrenergic receptors stimulate the growth of small mouse cholangiocytes Via calcium-dependent activation of nuclear factor of activated T cells 2 and specificity protein 1.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  103. DHIRAPONG A , Lleo A, Yang GX, Tsuneyama K, et al
    B cell depletion therapy exacerbates murine primary biliary cirrhosis.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  104. LIEN TH , Chang MH, Wu JF, Chen HL, et al
    Effects of the infant stool color card screening program on 5-year outcome of biliary atresia in taiwan.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  105. BRAEYE L , Vanheste R
    Biliary papillomatosis.
    Hepatology. 2010;52:1512-4.
    PubMed     Text format     Related articles   



    September 2010
  106. CSANAKY IL , Lu H, Zhang Y, Ogura K, et al
    Organic anion-transporting polypeptide 1b2 (Oatp1b2) is important for the hepatic uptake of unconjugated bile acids: Studies in Oatp1b2-null mice.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  107. MCCRANN CH , Boyer JL
    Small-duct sclerosing cholangitis associated with Schistosoma mansoni.
    Hepatology. 2010.
    PubMed     Text format     Related articles   



  108. QUENTIN M , Scherer A
    The "von Meyenburg complex".
    Hepatology. 2010;52:1167-8.
    PubMed     Text format     Related articles   



  109. REMBACZ KP , Woudenberg J, Hoekstra M, Jonkers EZ, et al
    Unconjugated bile salts shuttle through hepatocyte peroxisomes for taurine conjugation.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



    August 2010
  110. TSIKAS D , Zoerner AA, Gutzki FM, Rossi R, et al
    On the mercapturic acid pathway of nitric oxide: is S-nitrosoglutathione present in the bile?
    Hepatology. 2010.
    PubMed     Text format     Related articles   



  111. BRUFAU G , Stellaard F, Prado K, Bloks VW, et al
    Improved glycemic control with colesevelam treatment in patients with type 2 diabetes is not directly associated with changes in bile acid metabolism.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  112. LIU Z , Ma Y, Qin H
    Combinative strategy using tamoxifen and other chemotherapeutic drugs for cholangiocarcinoma chemotherapy.
    Hepatology. 2010.
    PubMed     Text format     Related articles   



  113. WOO K , Sathe M, Kresge C, Esser V, et al
    Adenosine triphosphate release and purinergic (P2) receptor-mediated secretion in small and large mouse cholangiocytes.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  114. RAHMANI R , Ivanina E, Yang L
    An unusual cause of acute cholangitis.
    Hepatology. 2010;52:795-6.
    PubMed     Text format     Related articles   



  115. RODRIGUEZ-ORTIGOSA CM , Banales JM, Olivas I, Uriarte I, et al
    Biliary secretion of S-nitrosoglutathione is involved in the hypercholeresis induced by ursodeoxycholic acid in the normal rat.
    Hepatology. 2010;52:667-77.
    PubMed     Text format     Related articles    Abstract available



  116. LINDKVIST B , Benito de Valle M, Gullberg B, Bjornsson E, et al
    Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in sweden.
    Hepatology. 2010;52:571-7.
    PubMed     Text format     Related articles    Abstract available



  117. AL-HARTHY N , Kumagi T, Coltescu C, Hirschfield GM, et al
    The specificity of fatigue in primary biliary cirrhosis: Evaluation of a large clinic practice.
    Hepatology. 2010;52:562-70.
    PubMed     Text format     Related articles    Abstract available



  118. FINGAS CD , Blechacz BR, Smoot RL, Guicciardi ME, et al
    A smac mimetic reduces TNF Related Apoptosis Inducing Ligand (TRAIL)-induced invasion and metastasis of cholangiocarcinoma cells.
    Hepatology. 2010;52:550-61.
    PubMed     Text format     Related articles    Abstract available



    July 2010
  119. BOAGLIO AC , Zucchetti AE, Sanchez Pozzi EJ, Pellegrino JM, et al
    Phosphoinositide 3-kinase/protein kinase B signaling pathway is involved in estradiol 17beta-d-glucuronide-induced cholestasis: Complementarity with classical protein kinase c.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  120. GUEST I , Ilic Z, Sell S
    Age dependence of oval cell responses and bile duct carcinomas in male fischer 344 rats fed a cyclic choline-deficient, ethionine-supplemented diet.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  121. MILONA A , Owen BM, Cobbold JF, Willemsen EC, et al
    Raised hepatic bile acid concentrations during pregnancy in mice are associated with reduced farnesoid X receptor function.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  122. STEIN LL , Gonda TA, Stevens PD, Brown RS Jr, et al
    Diagnostic utility of chromosome 17 and p16 abnormalities in fluorescence in situ hybridization tests in primary sclerosing cholangitis.
    Hepatology. 2010;52:393-4.
    PubMed     Text format     Related articles   



  123. BANGARULINGAM SY , Bjornsson E, Enders F, Fritcher EG, et al
    Reply: Diagnostic Utility of Chromosome 17 and p16 Abnormalities in Fluorescence In Situ Hybridization Tests in Primary Sclerosing Cholangitis.
    Hepatology. 2010;52:394-5.
    PubMed     Text format     Related articles   



  124. JURAN BD , Atkinson EJ, Larson JJ, Schlicht EM, et al
    Carriage of a tumor necrosis factor polymorphism amplifies the cytotoxic T-lymphocyte antigen 4 attributed risk of primary biliary cirrhosis: Evidence for a gene-gene interaction.
    Hepatology. 2010;52:223-9.
    PubMed     Text format     Related articles    Abstract available



  125. ZHANG W , Tsuda M, Yang GX, Tsuneyama K, et al
    Deletion of interleukin-6 in mice with the dominant negative form of transforming growth factor beta receptor II improves colitis but exacerbates autoimmune cholangitis.
    Hepatology. 2010;52:215-22.
    PubMed     Text format     Related articles    Abstract available



  126. GLASER S , Lam IP, Franchitto A, Gaudio E, et al
    Knockout of secretin receptor reduces large cholangiocyte hyperplasia in mice with extrahepatic cholestasis induced by bile duct ligation.
    Hepatology. 2010;52:204-14.
    PubMed     Text format     Related articles    Abstract available



  127. MATSUDA A , Kuno A, Kawamoto T, Matsuzaki H, et al
    Wisteria floribunda agglutinin-positive mucin 1 is a sensitive biliary marker for human cholangiocarcinoma.
    Hepatology. 2010;52:174-82.
    PubMed     Text format     Related articles    Abstract available



  128. SILVEIRA MG , Brunt EM, Heathcote J, Gores GJ, et al
    American association for the study of liver diseases endpoints conference: Design and endpoints for clinical trials in primary biliary cirrhosis.
    Hepatology. 2010;52:349-59.
    PubMed     Text format     Related articles   



  129. CHEN HF , Chen P, Li CY
    Risk of malignant neoplasms of liver and biliary tract in diabetic patients with different age and sex stratifications.
    Hepatology. 2010;52:155-63.
    PubMed     Text format     Related articles    Abstract available



    June 2010
  130. KUIPER EM , van Erpecum KJ, Beuers U, Hansen BE, et al
    The potent bile acid sequestrant colesevelam is not effective in cholestatic pruritus: Results of a double-blind, randomized, placebo-controlled trial.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  131. BEUERS U , Hohenester S, de Buy Wenniger LJ, Kremer AE, et al
    The biliary HCO(3) (-) umbrella: A unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  132. YEH TH , Krauland L, Singh V, Zou B, et al
    Liver-specific beta-catenin knockout mice have bile canalicular abnormalities, bile secretory defect, and intrahepatic cholestasis.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  133. DESAI MS , Shabier Z, Taylor M, Lam F, et al
    Hypertrophic cardiomyopathy and dysregulation of cardiac energetics in a mouse model of biliary fibrosis.
    Hepatology. 2010;51:2097-107.
    PubMed     Text format     Related articles    Abstract available



  134. VERHULST PM , van der Velden LM, Oorschot V, van Faassen EE, et al
    A flippase-independent function of ATP8B1, the protein affected in familial intrahepatic cholestasis type 1, is required for apical protein expression and microvillus formation in polarized epithelial cells.
    Hepatology. 2010;51:2049-60.
    PubMed     Text format     Related articles    Abstract available



  135. VILANA R , Forner A, Bianchi L, Garcia-Criado A, et al
    Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound.
    Hepatology. 2010;51:2020-9.
    PubMed     Text format     Related articles    Abstract available



  136. DAWSON PA
    Liver disease without flipping: new functions of ATP8B1, the protein affected in familial intrahepatic cholestasis type 1.
    Hepatology. 2010;51:1885-7.
    PubMed     Text format     Related articles   



  137. LLEO A , Bowlus CL, Yang GX, Invernizzi P, et al
    Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



    May 2010
  138. ZHANG Z , Oyesanya RA, Campbell DJ, Almenara JA, et al
    Preclinical assessment of simultaneous targeting of epidermal growth factor receptor (ErbB1) and ErbB2 as a strategy for cholangiocarcinoma therapy.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



  139. GILL RM , Ferrell LD
    Vanishing bile duct syndrome associated with peripheral T cell lymphoma, not otherwise specified, arising in a posttransplant setting.
    Hepatology. 2010;51:1856-7.
    PubMed     Text format     Related articles   



  140. ZEIN CO
    Clearing the smoke in chronic liver diseases.
    Hepatology. 2010;51:1487-90.
    PubMed     Text format     Related articles   



    April 2010
  141. MCDONALD GB
    Hepatobiliary complications of hematopoietic cell transplantation, 40 years on.
    Hepatology. 2010;51:1450-60.
    PubMed     Text format     Related articles    Abstract available



  142. PAUMGARTNER G
    Biliary physiology and disease: reflections of a physician-scientist.
    Hepatology. 2010;51:1095-106.
    PubMed     Text format     Related articles    Abstract available



  143. DRANOFF JA , Wells RG
    Portal fibroblasts: Underappreciated mediators of biliary fibrosis.
    Hepatology. 2010;51:1438-44.
    PubMed     Text format     Related articles    Abstract available



    March 2010
  144. SINAKOS E , Marschall HU, Kowdley KV, Befeler A, et al
    Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progression.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



    January 2010
  145. DAVIT-SPRAUL A , Fabre M, Branchereau S, Baussan C, et al
    ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): Phenotypic differences between PFIC1 and PFIC2 and natural history.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available



    November 2009
  146. YANG H , Ko K, Xia M, Li TW, et al
    Induction of avian musculoaponeurotic fibrosarcoma proteins by toxic bile acid inhibits expression of glutathione synthetic enzymes and contributes to cholestatic liver injury in mice.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available



  147. BLAAS L , Kornfeld JW, Schramek D, Musteanu M, et al
    Disruption of the growth hormone-Signal transducer and activator of transcription 5-Insulinlike growth factor 1 axis severely aggravates liver fibrosis in a mouse model of cholestasis.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available



  148. SPARKS EE , Huppert KA, Brown MA, Washington MK, et al
    Notch signaling regulates formation of the three-dimensional architecture of intrahepatic bile ducts in mice.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available



    October 2009
  149. BRACONI C , Huang N, Patel T
    MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available



    September 2009
  150. RODERFELD M , Rath T, Voswinckel R, Dierkes C, et al
    Bone marrow transplantation demonstrates medullar origin of CD34(+) fibrocytes and ameliorates hepatic fibrosis in Abcb4(-/-) mice.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available



  151. CHAPMAN R , Fevery J, Kalloo A, Nagorney DM, et al
    Diagnosis and management of primary sclerosing cholangitis.
    Hepatology. 2009;51:660-678.
    PubMed     Text format     Related articles   



Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: